GAMMA Investing LLC Takes Position in MetLife, Inc. (NYSE:MET)

GAMMA Investing LLC acquired a new stake in MetLife, Inc. (NYSE:METFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 3,395 shares of the financial services provider’s stock, valued at approximately $235,000.

Other hedge funds also recently made changes to their positions in the company. Criterion Capital Advisors LLC acquired a new stake in MetLife during the 4th quarter worth approximately $26,000. Quintet Private Bank Europe S.A. bought a new position in MetLife during the 3rd quarter worth $28,000. Planned Solutions Inc. bought a new position in MetLife during the 4th quarter worth $28,000. Tennessee Valley Asset Management Partners bought a new position in MetLife during the 4th quarter worth $34,000. Finally, Headlands Technologies LLC bought a new position in MetLife during the 3rd quarter worth $36,000. 89.81% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Down 1.1 %

Shares of NYSE:MET opened at $71.90 on Friday. The company has a market capitalization of $51.99 billion, a price-to-earnings ratio of 39.29, a P/E/G ratio of 0.55 and a beta of 1.04. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. The business’s 50-day moving average is $71.41 and its 200-day moving average is $67.09. MetLife, Inc. has a 1 year low of $48.95 and a 1 year high of $74.68.

MetLife (NYSE:METGet Free Report) last issued its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts’ consensus estimates of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The firm had revenue of $18.72 billion during the quarter, compared to the consensus estimate of $18.07 billion. Equities research analysts predict that MetLife, Inc. will post 8.71 earnings per share for the current year.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be given a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 3.03%. This is a positive change from MetLife’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, May 6th. MetLife’s payout ratio is presently 113.66%.

Analysts Set New Price Targets

A number of research firms have commented on MET. Wells Fargo & Company raised their price objective on MetLife from $83.00 to $86.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. UBS Group decreased their price target on MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research note on Monday, February 5th. Morgan Stanley lifted their price target on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. Piper Sandler lifted their price target on MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. Finally, The Goldman Sachs Group upgraded MetLife from a “neutral” rating to a “buy” rating and lifted their price target for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.23.

Get Our Latest Research Report on MET

Insider Activity at MetLife

In related news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.